# The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats

Study · id `cardio:ct-nct04163835` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04163835](<https://clinicaltrials.gov/study/NCT04163835>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04163835

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT04163835. Randomized; double masking; primary purpose treatment. Start 2015-09-01 (actual); primary completion 2022-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT04163835, source copy `cardio:ctgov-nct04163835-2022-11-18`, retrieved 2026-10-26)
- Started: 2015-09-01 (actual) (ClinicalTrials.gov record NCT04163835, source copy `cardio:ctgov-nct04163835-2022-11-18`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (anticipated) (ClinicalTrials.gov record NCT04163835, source copy `cardio:ctgov-nct04163835-2022-11-18`, retrieved 2026-10-26)
- Completion: 2023-12-31 (anticipated) (ClinicalTrials.gov record NCT04163835, source copy `cardio:ctgov-nct04163835-2022-11-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04163835, source copy `cardio:ctgov-nct04163835-2022-11-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04163835-2022-11-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats
- Condition: Atrial Premature Complexes
- Intervention (Drug): Normal-dose Wenxin Granules
- Intervention (Drug): 1/2 Normal-dose Wenxin Granules
- Intervention (Drug): Twice Normal-dose Wenxin Granules
- Intervention (Drug): Placebo
- Lead sponsor: China Academy of Chinese Medical Sciences
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Premature heartbeats (`cardio:premature-heartbeats`)
- Registry lists this organization as the lead sponsor: China Academy of Chinese Medical Sciences (`cardio:org-china-academy-of-chinese-medical-sciences`)

## Provenance

Content hash: a1b3a7d0c98e03e2d0f13ee4d130e0c6a7de4ebf3dcb399633413915d2b7a300
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
